Dose vs response of tetrahydroannabinol (THC) vs prochlorperazine as chemotherapy antiemetics. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis. Ungerleider JT, Sarna G, Fairbanks LA, Goodnight J, Andrysiak T, Jamison K.
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, Nunn AJ, Teare LJ, Fox PJ, Thompson AJ. A randomised controlled study of Sativex in patients with symptoms of spasticity due to multiple sclerosis.A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy.Colls BM, Ferry DG, Gray AJ, Harvey VJ, Mc Queen EG.Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers. Deutsch SI, Rosse RB, Connor JM, Burket JA, Murphy ME, Fox FJ.Current status of cannabis treatment of multiple sclerosis with an illustrative case presentation of a patient with MS, complex vocal tics, paroxysmal dystonia, and marijuana dependence treated with dronabinol. Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial.